Main Article Content
Objectives: The aims of this study to assess the practice of preventing cervical cancer of 15 - 49 years old and having gynecological examination women at Lam Dong General Hospital. Research method: A cross-sectional description. Interviewed practice about cervical cancer prevention of 400 women. Results: Over the course of the study, 400 women showed the number of women who had not been vaccinated is still high at 85.5%, the rate who had not been screened for cervical cancer is 62.3%. Based on the results of the study, we recommend that reproductive age women should be communicated more frequently about HPV vaccination and periodic cervical cancer screening to prevent cervical cancer.
Cervical cance, prevention, reproductive age women
2. Bruni L, Albero G, Serrano B et al., Human Papillomavirus and Related Diseases in Viet Nam, ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre), 2018.
3. Ha BTT, Knowledge and practices on the cervical cancer prevention and associated factors among 35 - 60 years old married women in An Bai, Quynh Phu district, Thai Binh province, Master's Thesis in Public Health, Ha Noi University of public heallth, 2013. (in Vietnamese)
4. Ha DT, Results of the 2132 women’s Pap smear in Lam Dong province in 2013, Ho Chi Minh City Journal of Medicine, 2014; 18(5): 80 – 83. (in Vietnamese)
5. Ministry of Health, National action plan for prevention and control of cervical cancer 2016-2025, Hanoi, 2016. (in Vietnamese)
6. Nhu DD, Knowledge, attitude and practice about prevention cervical cancer of 3rd - year female students at University of Social Sciences and Humanities in 2014, Journal of preventive medicine, 2016; 26(4): 117. (in Vietnamese)
7. Okunowo AA, Daramola ES, Soibi AP et al., Women's knowledge of cervical cancer and uptake of Pap smear testing and the factors influencing it in a Nigerian tertiary hospital, Journal of Cancer Research and Practice, 2018; 5(3): 105-111.
8. Saraiya M, Unger ER, Thompson TD et al., US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccine., J Natl Cancer Inst., 2015; 107(6): 86.